Indication

Survival Without Progression

1 clinical trial

1 product

Clinical trial

A Phase II Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing Solid Tumours.

Status: Completed, Estimated PCD: 2015-09-11

Product